Skip to main content
. 2023 Jul 14;10(3):172–187. doi: 10.1055/s-0043-1771193

Table 11. The mean and median cfDNA dosage values and the number of collected samples were subdivided by tumor origin (intestinal, pulmonary, and other sites) and recorded for the various monitoring times (T0–T10).

T0 T1 T2 T3 T4 T5 T6 T7 T8 T9 T10
cfDNA mean a (ng/mL) Lung 976.8 157.0 193.3 275.0 248.6 186.0 170.0 / / / /
Intestine 306.5 299.0 693.4 537.2 1,562.6 293.2 193.7 300.0 506.0 1,115.5 250.0
Others 550.6 96.6 286.0 228 218 211 / 416 / / /
Samples ( n ) Lung 17 5 8 3 5 3 2 3 0 0 0
Intestine 14 7 5 6 5 4 4 3 3 3 3
Others 8 3 1 1 1 1 0 1 0 0 0
cfDNA median a (ng/mL) Lung 167.0 170.0 194.0 275 265.0 186.0 170.0 / / / /
Intestine 182.0 237.0 294.0 245.5 213.0 284.0 212.0 300.0 506.0 1,115.5 289.0
Others 263.5 109.0 286.0 228.0 218.0 211.0 / 416.0 / / /

Abbreviations: cfDNS, circulating free DNA.

a

The variability, in terms of the inaccuracy of the measurement for cfDNA mean and median values, is 5% (95% confidence interval).